About us

Chief Executive Officer at Captor Therapeutics. 30 years’ experience of Biotech senior management in the UK, USA, France, Switzerland, Australia and Poland, leading 12 major license agreements, 6 private investor rounds and 3 IPOs.
Awarded a PhD in biochemistry from Strathclyde University, Glasgow, and CEP diploma from the London Business School. I am a keen amateur musician and enjoy hiking, sailing, skiing and photography.

Michał Walczak is a Chief Scientific officer, CSO, responsible for R&D and strategy. He obtained a PhD degree from the Swiss Federal Institute of Technology in Zurich , ETH Zurich, and studied at the University of Wroclaw and University of Virginia. He completed his postdoctoral training at the Friedrich Miescher Institute for Biomedical Research in Basel, which is a part of Novartis Institutes for Biomedical Research. Roles played by the member of the Management Board in other companies: Not applicable.

I am a co-founder and SVP Chemistry of Captor Therapeutics who builds scientific strategy and oversees chemistry efforts.

Prior to Captor, I served as Global Head at Center for Proteomic Chemistry at Novartis Institutes for Biomedical Research, where I played key roles in multiple successful discovery and development programs, e.g. Afinitor^TM and in-licensing of Gilenya^TM.

I studied and received PhD in organic chemistry from EPFL Lausanne.

In my free time I enjoy cycling and travelling.

Head of Operations at Captor Therapeutics. Ph.D. in Biochemistry from the University of Wroclaw and Executive MBA from WSB Wroclaw University. Having 15 years of R&D experience, I am responsible for day-to-day operations, overseeing the implementation of optimal processes, standards, and solutions to help the business run smoothly. In my role I have the opportunity for continuous development, and solving daily challenges gives me a lot of satisfaction. As for hobbies, I am an avid traveller and book lover.

Chief Medical officer (CMO) at Captor Therapeutics responsible for all aspects of clinical development. Obtained a medical degree from Trinity College Dublin in 1989 and has practiced in haemato-oncology for over 30 years in both clinical practice and the pharmaceutical industry. Previous positions include CMO at oncology biotech’s including most recently RedX pharma (U.K.) and Lytix Biopharma Inc (Norway) and oncology drug development roles at Roche and Eli Lilly. Dr. Saunders has acted as an oncology consultant for multiple pharma/biotech companies and holds a diploma in Pharmaceutical Medicine and is a fellow of the Royal College of Physicians, United Kingdom. 

I am the Head of Biology at Captor Therapeutics, where I oversee and coordinate the preclinical development of compounds, including translational studies. I obtained my Ph.D. in Molecular and Cellular Biology from the University of Cologne, Germany. With over 30 years of experience in my field, I have held leadership positions and managed projects, teams, and departments in both large pharmaceutical and small biotech companies, primarily in the United States. I have led the development of several novel drug candidates that have entered clinical evaluation, focusing on both oncology and immune diseases.

Outside of work, I am passionate about skiing and mountain biking.

I head the Structure, Fragments and Biophysics department where we employ a wide range of in vitro methods to support drug discovery. Previously I worked at AstraZeneca (Cambridge, UK), where I contributed to discovery of several anti-cancer drug candidates. I have a Ph.D. degree from Technical University Munich. In my spare time, I like bicycles and jazz music.

I am a trained medical doctor with a specialization and PhD in Internal Medicine with over twenty years of experience in the clinical development of innovative drugs, both in global pharmaceutical companies, global CRO and biotechnology company. At Captor Therapeutics, I am responsible for the clinical development processes of drug candidates. In my spare time, I am passionate about travel, water sports, cycling and skiing.

Director of Business Development at Captor Therapeutics with more than 20 years’ experience in international business development and alliance management. Previously worked in a number of early-stage European biotech & medtech companies supporting partnering activities, predominantly in oncology and rare diseases. Originally trained as a biologist with a PhD from the University of Southampton and an MBA from Cranfield School of Management.

As the Vice President of Early Discovery, I oversee cross-functional discovery activities within projects.  I hold a Ph.D. from Charles University and completed my post-doctoral training in molecular pharmacology at the University of Glasgow.  With over 25 years of experience in the industry, I have progressed from early drug discovery to clinical development while leading cross-functional teams, notably at AstraZeneca R&D and SOTIO Biotech. In my leisure time, I enjoy walking in nature and reading books.

Marta Tomaszewska is VP of People and Culture at Captor Therapeutics. She is a graduate of Wroclaw University of Economics and SWPS University. She has nearly 20 years of professional experience in HR in Polish and foreign companies. She implements HR tools and development projects including recruitment, onboarding, talent management, competence development, and employee engagement building. Supports the Management Board and Managers in making business decisions. Values active recreation, travel, time spent with loved ones, and moments on the mat with yoga.